Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells.
about
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses.Targeting the PTPome in human disease.Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases.Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases.Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla
P2860
Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Suramin, an experimental chemo ...... th of certain malignant cells.
@ast
Suramin, an experimental chemo ...... th of certain malignant cells.
@en
type
label
Suramin, an experimental chemo ...... th of certain malignant cells.
@ast
Suramin, an experimental chemo ...... th of certain malignant cells.
@en
prefLabel
Suramin, an experimental chemo ...... th of certain malignant cells.
@ast
Suramin, an experimental chemo ...... th of certain malignant cells.
@en
P2093
P2860
P356
P1476
Suramin, an experimental chemo ...... th of certain malignant cells.
@en
P2093
P2860
P304
P356
10.1172/JCI115708
P407
P577
1992-04-01T00:00:00Z